Physician profile
Chris Benge
NPI 1245900398
$408.55
in general payments reported to CMS, 2019-2025
10 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $38.01 · 2023: $23.46 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $222.97 | 2023-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $39.40 | 2025 | Caplyta |
| Lilly USA, LLC | $22.75 | 2025 | Jardiance |
| Idorsia Pharmaceuticals US INC | $20.90 | 2022 | |
| Dynavax Technologies Corporation | $18.68 | 2025 | Heplisav-B |
| Astrazeneca Pharmaceuticals LP | $18.39 | 2025 | Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $18.02 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.11 | 2022 | |
| Genzyme Corporation | $16.22 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $14.11 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Benge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.